Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-16-0541
Full Text
Open PDFAbstract
Available in full text
Date
March 6, 2017
Authors
Publisher
American Association for Cancer Research (AACR)